Lamotrigine in the treatment of schizoaffective disorder [PDF]
, 1998 There is accumulating evidence for the efficacy of lamotrigine in the treatment of bipolar disorder, including bipolar depression, both as monotherapy and in combination with sodium valproate.
Erfurth, Andreas +2 more
core +1 more source
Psychoanalytic and psychodynamic therapies for depression. The evidence base. [PDF]
, 2008 David Taylor, a consultant psychotherapist at the Tavistock & Portman NHS Foundation Trust (120 Belsize Lane, London NW3 5BA, UK. Email: dtaylor@tavi-port.nhs.uk), is the clinical lead of the Tavistock Adult Depression Study (a randomised controlled ...
Beutel +18 more
core +1 more source
A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression
Neuropsychiatric Disease and Treatment, 2022 Phern Chern Tor,1 Nurmiati Amir,2 Johnson Fam,3 Roger Ho,3 Pichai Ittasakul,4 Margarita M Maramis,5 Benita Ponio,6 Dharmawan Ardi Purnama,7 Wanida Rattanasumawong,8 Elizabeth Rondain,9 Ahmad Hatim Bin Sulaiman,10 Kannokarn Wiroteurairuang,11 Kok Yoon ...
Tor PC +12 more
doaj
Annals of General Psychiatry, 2019 Background Treatment-resistant depression (TRD) may represent a substantial proportion of major depressive disorder (MDD); however, the risk of mortality in TRD is still incompletely assessed. Methods Data were obtained from Optum Clinformatics™ Extended,
Gang Li +8 more
doaj +1 more source
Bipolar mood disorder and treatment-resistant depression [PDF]
Annals of General Psychiatry, 2010 Two lines of evidence point to the relationship between bipolar mood disorder and treatment-resistant depression. First, the frequency of suboptimal response to antidepressant drugs is significantly higher in bipolar than in unipolar mood disorder. Secondly, the first and the second generation mood stabilizing drugs are efficacious for augmentation of ...
openaire +2 more sources
The impact of high frequency repetitive transcranial magnetic stimulation on fine motor function in medication resistant major depression [PDF]
, 2012 <b><i>Objectives:</i></b> Although high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the left dorsolateral prefrontal cortex (DLPFC) has been reported to improve mood symptoms in major depressive disorder (
Baeken, Chris +3 more
core +1 more source
Overcoming the myths of esketamine administration: different and not difficult
Frontiers in Psychiatry, 2023 Intranasal esketamine for treatment-resistant depression has been introduced and approved by the FDA and EMA in 2019 and 2020, respectively. Since then, the administration practices were found different among countries. Major depression has a high impact
Florian Buchmayer, Siegfried Kasper
doaj +1 more source
Accelerated intermittent theta burst stimulation for suicide risk in therapy-resistant depressed patients : a randomized, sham-controlled trial [PDF]
, 2016 Objectives: We aimed to examine the effects and safety of accelerated intermittent Theta Burst Stimulation (iTBS) on suicide risk in a group of treatment-resistant unipolar depressed patients, using an extensive suicide assessment scale.
Audenaert, Kurt +5 more
core +3 more sources
Characterizing Treatment-Resistant Anorexia Nervosa
Frontiers in Psychiatry, 2021 Background: The issue of treatment resistance in eating disorder care is controversial. Prior research has identified multiple failed treatment attempts as a common criterion for severe and enduring anorexia nervosa, but little is known about patients ...
Sarah Smith +2 more
doaj +1 more source
Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study. [PDF]
, 2016 We studied peripheral leukocyte telomere length (LTL) as a predictor of antidepressant response to PPAR-γ agonist in patients with unremitted depression.
Blackburn, E +4 more
core +1 more source